30 results
Type of content
News Remove News filter
-
List item
Press release: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU
Last updated: 15/10/2018under increased supervision; Aurobindo Pharma stopped from supplying … Aurobindo Pharma stopped from supplying … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2020
CHMP, Last updated: 31/01/2020bempedoic acid / ezetimibe) for the treatment of primary … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2013
CHMP, Last updated: 20/09/2013Marketing-authorisation holder Aurobindo Pharma (Malta) Limited More … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 15-18 February 2010
CHMP, Last updated: 19/02/2010treatment of colesevelam with ezetimibe, with or without a statin … treatment of colesevelam with ezetimibe, with or without a statin … -
List item
Press release: European Medicines Agency confirms recommendation to suspend Tredaptive, Pelzont and Trevaclyn
CHMP, Last updated: 18/01/2013or simvastatin 40 mg plus ezetimibe 10 mg to achieve a total … or simvastatin 40 mg plus ezetimibe 10 mg to achieve a total … -
List item
Press release: EMA recommends suspension of medicines due to unreliable studies from Micro Therapeutic Research Labs
Last updated: 24/03/2017 -
List item
News: EMA 2017 annual report published
Last updated: 02/05/2018 -
List item
Press release: Meeting highlights from the Paediatric Committee: 6 - 8 May 2008
PDCO, Last updated: 15/05/2008diphtheriae CRM197 protein) and for ezetimibe. In addition, the Agency … -
List item
Press release: Meeting highlights from the Paediatric Committee: 12 - 14 March 2008
PDCO, Last updated: 25/04/2008therapeutic area of vaccines; Ezetimibe, from MSD-SP Limited, in the … -
List item
Press release: European Medicines Agency publishes 2012 annual report
Last updated: 16/04/2013 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 March 2021
PRAC, Last updated: 12/03/2021 -
List item
News: EMA publishes 2013 annual report
Last updated: 30/04/2014 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021
PRAC, Last updated: 09/07/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021
PRAC, Last updated: 29/10/2021 -
List item
News: Annual report 2011 shows continuously high level of activities
Last updated: 06/06/2012 -
List item
News: Annual report 2020 published
Last updated: 14/06/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
PRAC, Last updated: 30/09/2022 -
List item
Press release: Meeting highlights from the Paediatric Committee: 29 - 31 July 2008
PDCO, Last updated: 04/09/2008negative opinions for PIPs for ezetimibe and simvastatin, from Merck … -
List item
News: European Medicines Agency's 2010 annual report shows increase in activities
Last updated: 29/06/2011 -
List item
News: Feedback requested on the draft list of EU reference dates for periodic safety update reports in preparation for introduction of the new pharmacovigilance legislation
Last updated: 04/04/2012 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021
PRAC, Last updated: 01/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 March 2022
PRAC, Last updated: 11/03/2022 -
List item
News: Progress on science, medicines and health
Last updated: 10/05/2017 -
List item
News: EMA publishes annual report 2021
Last updated: 10/06/2022 -
List item
Press release: EMEA reports strong performance in regulatory and public-health activities in 2007; the outlook for 2008 is even higher application numbers and a focus on advanced-therapy medicines
Last updated: 10/03/2008